Grail (GRAL) stock shot up 33% Thursday, the day after the company announced a partnership with Quest (DGX) to expand ...

The stock's rise snapped a four-day losing streak.

Troy Tazbaz, director of the Food and Drug Administration’s Digital Health Center of Excellence, said Friday in a LinkedIn post that he is leaving the agency effective immediately. Tazbaz led the ...

The Arden Theatre Company’s world premiere of the play Holy Grail of Memphis by Philly playwright Michael Hollinger examines the legacy of these recordings and raises the question: Who does this music ...

09:37 EST Grail (GRAL) Inc trading halted, volatility trading pause Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>> See Insiders ...

GRAIL's founding was likely driven by Illumina's desire to realize more value from its NGS technology and a realization that costs and technological capabilities were reaching a point where liquid ...

Grail spun off from Illumina last year, and is developing a number of early detection cancer screening products. Last week, Grail said it sees fiscal 2025 sales of its Galleri blood test up 20% to ...

Illumina recently launched the MiSeq i100 and MiSeq i100 Plus Systems, two powerful, compact benchtop sequencers that incorporate more than 140 invention disclosures and 60 patent families.

Abbott expects to launch its first pulsed field ablation (PFA) device outside of the U.S. in 2025, CEO Robert Ford told investors on Wednesday. A company spokesperson said Abbott expects to receive a ...

Firstly, Illumina’s preliminary fourth-quarter revenue exceeded expectations, signaling the first instance of growth for the company in 2024, which is a positive indicator of its recovery ...